Migration stimulating activity in serum of breast cancer patients

M Picardo, S L Schor, A M Grey, A Howell, I Laidlaw, J Redford, A M Schor

    Research output: Contribution to journalArticlepeer-review

    19 Citations (Scopus)


    An assay to measure the ability to stimulate migration of fibroblasts into collagen gel was carried out on serum from treated and untreated breast cancer patients and from healthy controls. Migration stimulating activity was found in the serum of 10 (83%) of 12 untreated breast cancer patients immediately before surgical resection of the primary tumour and in 9 (75%) of them 4 days after resection; in 13 (93%) of 14 patients 1-13 years after tumour resection who had received adjuvant treatment; and in 2 (10%) of 20 healthy women matched for age. The migration stimulating activity in cancer patients' serum was indistinguishable from the migration stimulating factor produced in vitro by fetal and cancer patient skin fibroblasts in its behaviour in various biochemical fractionation procedures. The presence of this activity in the serum of treated breast cancer patients clearly distinguishes it from other oncofetal proteins, which all seem to be produced by tumours.

    Original languageEnglish
    Pages (from-to)130-3
    Number of pages4
    Issue number8734
    Publication statusPublished - 19 Jan 1991


    • Adult
    • Aged
    • Breast Neoplasms/blood
    • Cell Movement/physiology
    • Cytokines/blood
    • Female
    • Fibroblasts/physiology
    • Fibronectins
    • Humans
    • Middle Aged
    • Predictive Value of Tests


    Dive into the research topics of 'Migration stimulating activity in serum of breast cancer patients'. Together they form a unique fingerprint.

    Cite this